

Author: Ikari A. Nakajima K. Taki S. Suketa Y.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.451, Iss.2, 2002-09, pp. : 133-139
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content






By de Oliveira Elias M. de Lima W.T. Vannuchi Y.B. Marcourakis T. da Silva Z.L. Trezena A.G. Scavone C.
European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. :




Nitric Oxide and Cyclic GMP Signaling Pathway as a Focus for Drug Development
Current Medicinal Chemistry, Vol. 18, Iss. 22, 2011-08 ,pp. :